Tech Company Financing Transactions

Catabasis Pharmaceuticals Funding Round

Advanced Technology Ventures, Clarus and MedImmune Ventures invested in a $8 million Series A funding round for Catabasis Pharmaceuticals. The funding round was announced by the company on 12/13/2011.

Transaction Overview

Announced On
12/13/2011
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Investors

Advanced Technology Ventures (Christian Cortis)

Clarus (Jeffrey Leiden)

MedImmune Ventures (Maggie LeFlore)

SV Health Investors (Michael Ross)

Proceeds Purpose
The new funding will be used to accelerate the development of CAT-2003, the company's omega-3 conjugated compound for patients with severe hypertriglyceridemia.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Kendall Sq. B14202
Cambridge, MA 02139
USA
Email Address
Overview
At Catabasis (NASDAQ: CATB) we are dedicated to the discovery and development of innovative, effective and safe medicines to treat inflammatory and metabolic diseases. We have assembled a team of highly motivated and experienced scientists who are committed to improving the lives of patients.
Profile
Catabasis Pharmaceuticals LinkedIn Company Profile
Social Media
Catabasis Pharmaceuticals Company Twitter Account
Company News
Catabasis Pharmaceuticals News
Facebook
Catabasis Pharmaceuticals on Facebook
YouTube
Catabasis Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jill Milne
  Jill Milne LinkedIn Profile  Jill Milne Twitter Account  Jill Milne News  Jill Milne on Facebook
Chief Financial Officer
Ian Sanderson
  Ian Sanderson LinkedIn Profile  Ian Sanderson Twitter Account  Ian Sanderson News  Ian Sanderson on Facebook
Chief Medical Officer
Joanne Donovan
  Joanne Donovan LinkedIn Profile  Joanne Donovan Twitter Account  Joanne Donovan News  Joanne Donovan on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/13/2011: WellnessFX venture capital transaction
Next: 12/13/2011: Life360 venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary